Basic Information
ID: ALA5135901
Type: Functional
Description: Antiviral activity against SARS-CoV-2 infected in eGFP expressing African green monkey Vero E6 cells assessed as reduction in virus-induced cytopathic effect measured after 4 days post infection by laser scanning microscopic analysis
Organism: Severe acute respiratory syndrome coronavirus 2
Cell type: Vero E6
Activity Charts
Bioactivity
Activity Types for Assay ALA5135901
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 319.88 | 4.81 | 4.81 |
| 279.34 | 4.40 | 4.40 |
| 378.52 | 5.41 | 5.41 |
| 291.27 | -1.86 | -1.86 |
| 372.47 | 5.57 | 5.57 |
| 370.45 | 5.66 | 5.66 |
| 502.66 | 7.77 | 7.77 |
| 481.64 | 5.89 | 5.89 |
| 364.49 | 5.02 | 5.02 |
| 498.62 | 6.14 | 6.14 |
| 438.57 | 5.43 | 5.43 |
| 450.58 | 5.57 | 5.57 |
| 408.54 | 5.42 | 5.42 |
| 528.65 | 6.15 | 6.15 |
| 438.57 | 5.43 | 5.43 |
| 408.54 | 5.42 | 5.42 |
| 558.68 | 6.16 | 6.16 |
| 421.54 | 3.98 | 3.98 |
| 394.52 | 5.03 | 5.03 |
| 528.65 | 6.15 | 6.15 |
| 558.68 | 6.16 | 6.16 |
| 438.57 | 5.43 | 5.43 |
| 541.69 | 5.90 | 5.90 |
| 468.59 | 5.44 | 5.44 |
| 498.62 | 6.14 | 6.14 |
| 436.55 | 5.18 | 5.18 |
| 484.60 | 6.10 | 6.10 |
| 450.58 | 5.57 | 5.57 |
| 388.51 | 5.51 | 5.51 |
| 438.57 | 5.43 | 5.43 |
| 405.54 | 4.76 | 4.76 |
| 541.69 | 5.90 | 5.90 |
| 436.55 | 5.18 | 5.18 |
| 511.67 | 5.90 | 5.90 |
| 452.56 | 2.52 | 2.52 |
| 436.55 | 5.18 | 5.18 |
| 528.65 | 6.15 | 6.15 |
| 320.44 | 4.62 | 4.62 |
| 360.91 | 5.34 | 5.34 |
| 333.44 | 4.16 | 4.16 |
| 406.53 | 5.17 | 5.17 |
| 436.55 | 5.18 | 5.18 |